750 related articles for article (PubMed ID: 19509315)
21. The α4β1 Homing Pathway Is Essential for Ileal Homing of Crohn's Disease Effector T Cells In Vivo.
Zundler S; Fischer A; Schillinger D; Binder MT; Atreya R; Rath T; Lopez-Pósadas R; Voskens CJ; Watson A; Atreya I; Neufert C; Neurath MF
Inflamm Bowel Dis; 2017 Mar; 23(3):379-391. PubMed ID: 28221249
[TBL] [Abstract][Full Text] [Related]
22. SFA-1/PETA-3 (CD151), a member of the transmembrane 4 superfamily, associates preferentially with alpha 5 beta 1 integrin and regulates adhesion of human T cell leukemia virus type 1-infected T cells to fibronectin.
Hasegawa H; Nomura T; Kishimoto K; Yanagisawa K; Fujita S
J Immunol; 1998 Sep; 161(6):3087-95. PubMed ID: 9743375
[TBL] [Abstract][Full Text] [Related]
23. Analysis of ligand-induced and ligand-attenuated epitopes on the leukocyte integrin alpha4beta1: VCAM-1, mucosal addressin cell adhesion molecule-1, and fibronectin induce distinct conformational changes.
Newham P; Craig SE; Clark K; Mould AP; Humphries MJ
J Immunol; 1998 May; 160(9):4508-17. PubMed ID: 9574557
[TBL] [Abstract][Full Text] [Related]
24. Effects of natalizumab on circulating B cells, T regulatory cells and natural killer cells.
Putzki N; Baranwal MK; Tettenborn B; Limmroth V; Kreuzfelder E
Eur Neurol; 2010; 63(5):311-7. PubMed ID: 20453514
[TBL] [Abstract][Full Text] [Related]
25. Vedolizumab for the treatment of IBD: a selective therapeutic approach targeting pathogenic a4b7 cells.
Jovani M; Danese S
Curr Drug Targets; 2013 Nov; 14(12):1433-43. PubMed ID: 23980911
[TBL] [Abstract][Full Text] [Related]
26. Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta.
Rihs S; Walker C; Virchow JC; Boer C; Kroegel C; Giri SN; Braun RK
Am J Respir Cell Mol Biol; 1996 Nov; 15(5):600-10. PubMed ID: 8918367
[TBL] [Abstract][Full Text] [Related]
27. Vedolizumab is associated with changes in innate rather than adaptive immunity in patients with inflammatory bowel disease.
Zeissig S; Rosati E; Dowds CM; Aden K; Bethge J; Schulte B; Pan WH; Mishra N; Zuhayra M; Marx M; Paulsen M; Strigli A; Conrad C; Schuldt D; Sinha A; Ebsen H; Kornell SC; Nikolaus S; Arlt A; Kabelitz D; Ellrichmann M; Lützen U; Rosenstiel PC; Franke A; Schreiber S
Gut; 2019 Jan; 68(1):25-39. PubMed ID: 29730603
[TBL] [Abstract][Full Text] [Related]
28. A cyclic hexapeptide is a potent antagonist of alpha 4 integrins.
Vanderslice P; Ren K; Revelle JK; Kim DC; Scott D; Bjercke RJ; Yeh ET; Beck PJ; Kogan TP
J Immunol; 1997 Feb; 158(4):1710-8. PubMed ID: 9029107
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte homing antagonists in the treatment of inflammatory bowel diseases.
Saruta M; Papadakis KA
Gastroenterol Clin North Am; 2014 Sep; 43(3):581-601. PubMed ID: 25110260
[TBL] [Abstract][Full Text] [Related]
30. Alpha 4 beta 7 integrin mediates B cell binding to fibronectin and vascular cell adhesion molecule-1. Expression and function of alpha 4 integrins on human B lymphocytes.
Postigo AA; Sánchez-Mateos P; Lazarovits AI; Sánchez-Madrid F; de Landázuri MO
J Immunol; 1993 Sep; 151(5):2471-83. PubMed ID: 7689608
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells.
Picarella D; Hurlbut P; Rottman J; Shi X; Butcher E; Ringler DJ
J Immunol; 1997 Mar; 158(5):2099-106. PubMed ID: 9036954
[TBL] [Abstract][Full Text] [Related]
32. Alpha 4 beta 1 recognition of the Hep II domain of fibronectin is constitutive on some hemopoietic cells but requires activation on others [corrected].
Sánchez-Aparicio P; Ferreira Júnior OC; Garcia-Pardo A
J Immunol; 1993 Apr; 150(8 Pt 1):3506-14. PubMed ID: 8280202
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of eosinophilia in vivo by a small molecule inhibitor of very late antigen (VLA)-4.
Okigami H; Takeshita K; Tajimi M; Komura H; Albers M; Lehmann TE; Rölle T; Bacon KB
Eur J Pharmacol; 2007 Mar; 559(2-3):202-9. PubMed ID: 17234179
[TBL] [Abstract][Full Text] [Related]
34. Recruitment and recirculation of leukocytes after an ultramarathon run: preferential homing of cells expressing high levels of the adhesion molecule LFA-1.
Gabriel H; Brechtel L; Urhausen A; Kindermann W
Int J Sports Med; 1994 Oct; 15 Suppl 3():S148-53. PubMed ID: 7883397
[TBL] [Abstract][Full Text] [Related]
35. Anti-integrin therapy for inflammatory bowel disease.
Park SC; Jeen YT
World J Gastroenterol; 2018 May; 24(17):1868-1880. PubMed ID: 29740202
[TBL] [Abstract][Full Text] [Related]
36. The leukocyte integrin alpha D beta 2 binds VCAM-1: evidence for a binding interface between I domain and VCAM-1.
Van der Vieren M; Crowe DT; Hoekstra D; Vazeux R; Hoffman PA; Grayson MH; Bochner BS; Gallatin WM; Staunton DE
J Immunol; 1999 Aug; 163(4):1984-90. PubMed ID: 10438935
[TBL] [Abstract][Full Text] [Related]
37. Adhesion of neutrophils to fibronectin: role of the cd66 antigens.
Nair KS; Zingde SM
Cell Immunol; 2001 Mar; 208(2):96-106. PubMed ID: 11333142
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of vedolizumab in the treatment of ulcerative colitis.
Domènech E; Gisbert JP
Gastroenterol Hepatol; 2016 Dec; 39(10):677-686. PubMed ID: 26948838
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of selective adhesion molecules in treatment of inflammatory bowel disease.
Ghosh N; Chaki R; Mandal SC
Int Rev Immunol; 2012 Oct; 31(5):410-27. PubMed ID: 23083349
[TBL] [Abstract][Full Text] [Related]
40. Adhesion of multiple myeloma peripheral blood B cells to bone marrow fibroblasts: a requirement for CD44 and alpha4beta7.
Masellis-Smith A; Belch AR; Mant MJ; Pilarski LM
Cancer Res; 1997 Mar; 57(5):930-6. PubMed ID: 9041197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
